Karo Pharma AB (publ)
KARBF News Today: Stay Updated with the Latest Karo Pharma AB (publ) News in Real Time
Find KARBF news now at Meyka AI. Stay informed with the latest Karo Pharma AB (publ) stocks updates, including price news, market analysis, and expert insights.
PHVS Maintained at Buy by Citigroup, April 2026
Citigroup maintains Buy rating on PHVS with price target raised to $52 from $48. Pharvaris stock at $29.14.
IMMP stock surges 97% on FDA orphan drug designation for efti
IMMP stock jumps 97% after FDA grants orphan drug designation for eftilagimod alfa in soft tissue sarcoma treatment.
SANA Maintained at Outperform by Wedbush, April 2026
Wedbush maintains Outperform rating on SANA, raising price target to $7 from $6. Stock trades at $3.48 with market cap of $929M.
Sensex Soars 1,263 Points, Nifty50 Closes at 24,231; SMIDs Shine, IndiGo Leads Gains
The Sensex witnessed a powerful rally in today’s trading session as Indian equity markets surged sharply on strong global cues and broad-based buying. The benchmark Sensex jumped 1,263 points, while the Nifty50 closed at 24,231, marking a strong bullish day for Dalal Street. We saw investors turning highly positive as buying spread across sectors, especially…
4597.T Stock Surges 3% on Heavy Trading Volume in Tokyo Market
Solasia Pharma 4597.T stock climbs 3% to ¥34 on 83.4M shares traded. Healthcare specialist shows mixed fundamentals with strong cash position.
CNWK.DE Stock Doubles on 100% Surge: co.don AG Biotech Rally
CNWK.DE stock surges 100% to €2.48 on XETRA. co.don AG biotech stock rallies on high volume trading activity.
IPSEY Maintained at Buy by Deutsche Bank, April 2026
Deutsche Bank maintained IPSEY at Buy with price target raised to EUR 183 from EUR 170 on April 14, 2026.
IN Stock Market Surges: Sensex Jumps 1,400 Points, Nifty Crosses 24,200
The Stock Market in India is showing strong momentum again. On April 15, 2026, benchmark indices surged sharply. The Sensex jumped around 1,200–1,400 points, while the Nifty crossed the key 24,200 level. This rally signals renewed investor confidence. We are seeing strong buying across sectors. The mood has clearly shifted to bullish after recent volatility….
LGND Maintained at Buy by H.C. Wainwright, April 2026
H.C. Wainwright maintained LGND at Buy with price target raised to $243 from $239 on April 14, 2026.